SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INFI, HRZN, VBLT
NEW YORK, Feb. 24, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI)’s merger with MEI Pharma, Inc. Per the merger agreement, pre-merger Infinity shareholders are expected to own approximately 42.0% of the outstanding equity of the combined company immediately following the merger. If you are an Infinity shareholder, click here to learn more about your rights and options.
Horizon Technology Finance Corporation (NASDAQ: HRZN)’s sale of its investment adviser, Horizon Technology Finance Management LLC, to an affiliate of Monroe Capital LLC. If you are a Horizon shareholder, click here to learn more about your rights and options.
Vascular Biogenics Ltd. (NASDAQ: VBLT)’s merger with Notable Labs, Inc. Per the merger agreement, Vascular shareholders are expected to own approximately 24% of the combined company. If you are a Vascular shareholder, click here to learn more about your rights and options.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
